Application of Assisted Design of Antibody and Protein Therapeutics (ADAPT) Improves Efficacy of a Clostridium Difficile Toxin a Single-Domain Antibody

Scientific Reports - United Kingdom
doi 10.1038/s41598-018-20599-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Antibody-Enhanced, Fc Gamma Receptor-Mediated Endocytosis of Clostridium Difficile Toxin A

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2009English

Application of Antibody-Mediated Therapy for Treatment and Prevention of Clostridium Difficile Infection

Frontiers in Microbiology
Microbiology
2018English

Arthritis in Pseudomembranous Colitis Associ Ated With an Antibody to Clostridium Difficile Toxin

Journal of the Royal Society of Medicine
Medicine
1980English

Nucleotide Sequence of Clostridium Difficile Toxin A

Nucleic Acids Research
Genetics
1990English

Considerations for the Design of Antibody-Based Therapeutics

Journal of Pharmaceutical Sciences
Pharmaceutical Science
2020English

Use of a Neutralizing Antibody Helps Identify Structural Features Critical for Binding of Clostridium Difficile Toxin TcdA to the Host Cell Surface

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2017English

IgG Antibody Response to Toxins a and B in Patients With Clostridium Difficile Infection

Clinical and Vaccine Immunology
MedicineImmunologyAllergyClinical BiochemistryMicrobiology
2012English

Crystal Structure of a Dimeric Anti-Her2 Human Single Domain Antibody

Acta Crystallographica Section A Foundations of Crystallography
2011English

Structural Basis for Chemically-Induced Homodimerization of a Single Domain Antibody

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy